Aliment Pharmacol Ther

1. GONCZI L, Lakatos L, Ilias A, Lakatos PL, et al
   Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras-Authors' reply.
   Aliment Pharmacol Ther. 2024;59:715-716.
   

   >> Share

   
   
2. LENFANT M, Verstockt B, Sabino J, Vermeire S, et al
   Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply.
   Aliment Pharmacol Ther. 2024;59:723-724.
   

   >> Share

   
   
3. LAHARIE D
   Letter: Should ulcerative colitis be monitored more or less invasively?
   Aliment Pharmacol Ther. 2024;59:721-722.
   

   >> Share

   
   
4. TASSONE D, Hartley I, Ding NS
   Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras.
   Aliment Pharmacol Ther. 2024;59:713-714.
   

   >> Share

   
   

   
   Am J Gastroenterol

5. HERFARTH H
   Dysplasia Detection in Inflammatory Bowel Disease: An Updated Meta-Analysis With Effect.
   Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002658.
   

   >> Share

   
   

   
   Dig Dis Sci

6. WEIDNER J
   IBD: Who Knows Best?
   Dig Dis Sci. 2024;69:324-325.
   

   >> Share

   
   

   
   Dis Colon Rectum

7. FICHERA A, Mangrola AM, Olortegui KS, Rebollo Salazar DA, et al
   Long-term Outcomes of the Kono-S Anastomosis: A Multicenter Study.
   Dis Colon Rectum. 2024;67:406-413.
   

   >> Share

   
   

   
   Gut

8. AN H, Zhong M, Gan H
   Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.
   Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904.
   

   >> Share

   
   

   
   J Clin Gastroenterol

9. DOLOVICH C, Shafer LA, Graff LA, Vagianos K, et al
   Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD.
   J Clin Gastroenterol. 2024;58:271-276.
   

   >> Share

   
   
10. KHAN N, Trivedi C, Shah Y, Patel M, et al
    Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort.
    J Clin Gastroenterol. 2024;58:277-280.
    

    >> Share

    
    

    
    Lancet Gastroenterol Hepatol

11. CICCOCIOPPO R, Gaspar L
    Haematopoietic stem-cell transplantation for patients with Crohn's disease: primum non nocere.
    Lancet Gastroenterol Hepatol. 2024 Feb 7:S2468-1253(24)00004.
    

    >> Share

    
    
12. LINDSAY JO, Hind D, Swaby L, Berntsson H, et al
    Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, ra
    Lancet Gastroenterol Hepatol. 2024 Feb 7:S2468-1253(23)00460.
    

    >> Share

    
    
13. BALDERRAMO D, Quaresma AB, Olivera PA, Savio MC, et al
    Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.
    Lancet Gastroenterol Hepatol. 2024;9:263-272.
    

    >> Share

    
    
14. RIVIERE P, Li Wai Suen C, Chaparro M, De Cruz P, et al
    Acute severe ulcerative colitis management: unanswered questions and latest insights.
    Lancet Gastroenterol Hepatol. 2024;9:251-262.
    

    >> Share

    
    

    
    PLoS One

15. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
    Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
    PLoS One. 2024;19:e0297836.
    

    >> Share

    
    

    
    Scand J Gastroenterol

16. ZEROUGA I, Valeur J, Sommer C, Cvancarova Smastuen M, et al
    Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study.
    Scand J Gastroenterol. 2024 Feb 15:1-9. doi: 10.1080/00365521.2024.2313056.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share